Osteotech Reports Second Quarter 2010 Financial Results

By · August 9, 2010 · No comments
Financial · Tagged: ,
OSTEOTECH, INC. and SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(dollars in thousands, except per share data)
(unaudited)
Three Months Six Months
Ending June 30, Ending June 30,
2010 2009 2010 2009
Revenue $   23,997 $      23,471 $      46,524 $      47,402
Cost of revenue 11,922 11,940 23,479 23,904
Gross profit 12,075 11,531 23,045 23,498
Marketing, selling and
general and administrative expenses 10,390 10,768 21,093 22,386
Research and development expenses 1,051 1,998 2,259 3,651
11,441 12,766 23,352 26,037
Operating income (loss) 634 (1,235) (307) (2,539)
Interest expense, net (316) (355) (655) (709)
Other (147) 131 (334) 48
Income (loss) before income taxes 171 (1,459) (1,296) (3,200)
Income tax provision (benefit) 56 (255) 172 (200)
Net income (loss) $        115 $      (1,204) $      (1,468) $      (3,000)
Income (loss) per share:
Basic $       0.01 $        (0.07) $        (0.08) $        (0.17)
Diluted $       0.01 $        (0.07) $        (0.08) $        (0.17)
Shares used in computing earnings (loss) per share:
Basic 18,069,937 18,004,217 18,098,827 17,882,059
Diluted 18,201,915 18,004,217 18,098,827 17,882,059

Posted By

Josh Sandberg has been recruiting specifically in the musculoskeletal industry for over 8 years. Throughout this time, he has been able to have a positive impact on his client’s businesses. With an educational background in Business Management, Josh is adept to discern which people will be the best fit for the company he is searching for by understanding how candidates will incorporate with the company’s culture and operational nuances. His experience as an executive in a start-up business has granted him the ability to understand what is takes to thrive in a hands–on environment, where desire and dedication are paramount for success.
←
→

© 2012 OrthoSpineNews